Study Summary
This trial is developing a care model to help people with metastatic lung cancer cope with uncertainty and understand their prognosis and treatment goals, so they can live well with cancer.
Eligible Conditions
- Non-Small Cell Lung Cancer
- Survivorship
- Palliative Care
- Non-Small Cell Lung Cancer (EGFR Positive)
- Stage IV Non-small Cell Lung Cancer
- Targeted Therapy
- ALK-positive Non-small Cell Lung Cancer
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 4 Secondary · Reporting Duration: 24 weeks
12 Weeks
Rate of acceptability at 12 weeks
24 Weeks
Rate of acceptability at 24 weeks
24 weeks
Distress related to prognostic uncertainty
Documentation of Goals and Values
Psychological Distress
Self efficacy
Uncertainty tolerance
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
POISE
1 of 1
Experimental Treatment
15 Total Participants · 1 Treatment Group
Primary Treatment: POISE · No Placebo Group · N/A
POISE
Behavioral
Experimental Group · 1 Intervention: POISE · Intervention Types: BehavioralTrial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 24 weeks
Who is running the clinical trial?
American Lung AssociationOTHER
28 Previous Clinical Trials
9,714 Total Patients Enrolled
Massachusetts General HospitalLead Sponsor
2,730 Previous Clinical Trials
31,219,408 Total Patients Enrolled
Laura A Petrillo, MDPrincipal InvestigatorMassachusetts General Hospital
1 Previous Clinical Trials
210 Total Patients Enrolled
Eligibility Criteria
Age 18+ · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:You are currently taking medication specifically designed to treat your condition.
You are a patient at the MGH Cancer Center.
Frequently Asked Questions
Are there open slots available for the current clinical trial?
"Clinicaltrials.gov indicates that this particular medical trial, which was first announced on October 1st 2022, is not presently seeking participants. Nonetheless, there are 2140 other studies currently recruiting patients." - Anonymous Online Contributor
Unverified Answer